Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

Study cohort and prospective sequencing

The study cohort comprised 6,927 tumour samples from 5,881 patients with breast cancer. All patients underwent prospective clinical tumour and normal DNA sequencing as part of their clinical care (February…

Continue Reading


News Source: www.nature.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *